福昕軟件(688095.SH):已成立文檔技術行業應用的研究小組,出具研究報吿,收集版式文檔在重點行業的應用案例
格隆匯6月2日丨福昕軟件(688095.SH)近期接受機構調研,交流環節中,就“我們提到醫療行業的文檔及電子票據,看起來這兩個市場的空間很大。但是我們如何切入?”,公司回覆稱,由於通用軟件在國內市場應用的廣度和深度不夠,功能比較淺,用户付費意願較低。只有對產品進行深度和高頻使用的情況下,用户才願意付費。基於此我們進入了垂直市場,着手進行一些行業應用的研究。我們已經成立了文檔技術行業應用的研究小組,出具研究報吿,收集版式文檔在重點行業的應用案例。電子票據的切入口是電子簽章,在供應鏈裏面加上新功能,比如在線簽約或內部系統對接,實現用户下單的同時廠家即發貨,且生成可追溯的過程文檔。切入醫療領域,則是做醫療數據的互聯互通。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.